Evidence map›Paper›PMID 22566883›Full record

ArticleFrontiers in immunology2011

Decay kinetics of HIV-1 specific T cell responses in vertically HIV-1 exposed seronegative infants.

Sara J Holditch, Emily M Eriksson, Leandro F Tarosso, Peter J Kuebler, Esper G Kallas, Erik K Nielsen, Andrew A Wiznia, Michael G Rosenberg, Douglas F Nixon

Abstract read
In one paragraph

Article in Frontiers in immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sara J HolditchDivision of Experimental Medicine, Department of Medicine, San Francisco General Hospital, University of California San Francisco San Francisco, CA, USA.
Emily M Eriksson
Leandro F Tarosso
Peter J Kuebler
Esper G Kallas
Erik K Nielsen
Andrew A Wiznia
Michael G Rosenberg
Douglas F Nixon

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Cell Mediated Immunity in HIV Infected ChildrenR01AI060379 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NIXON, DOUGLAS F · 2005 to 2009
$1.6M
Protective immunity in HIV Highly exposed but uninfected subjectsR21AI087131 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NIXON, DOUGLAS F · 2010 to 2011
$647k
Cell Mediated Immunity in HIV Infected ChildrenR21AI060379 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI NIXON, DOUGLAS F · 2004 to 2004
$374k
NCRR NIH HHS UL1 RR024131NIAID NIH HHS R01 AI060379NIAID NIH HHS R21 AI060379NIAID NIH HHS R21 AI087131
6 · The paper itself

Abstract

objectiveThe majority of infants born, in developed countries, to HIV-1 positive women are exposed to the HIV-1 virus in utero or peri/post-partum, but are born uninfected. We, and others, have previously shown HIV-1 specific T cell responses in HIV-1 exposed seronegative (HESN) neonates/infants. Our objective in this study was to examine the rate of decay in their HIV-1 specific T cell response over time from birth.

designCross-sectional and longitudinal studies of HIV-1 specific T cell responses in HESN infants were performed.

methodsPeripheral blood mononuclear cells (PBMC) were isolated from 18 HIV-1 DNA PCR negative infants born to HIV-1 infected mothers receiving care at the Jacobi Medical Center, Bronx, NY, USA. PBMC were examined for T cell responses to HIV-1 antigens by interferon-gamma (IFN-γ) ELISPOT.

resultsPBMC from 15 HESN neonates/infants were analyzed. We observed a decay of HIV-1 specific T cell responses from birth at a rate of -0.599 spot forming unit/10⁶ cells per day, with a median half-life decay rate of 21.38 weeks (13.39-115.8).

conclusionOur results support the dynamic nature of T cell immunity in the context of a developing immune system. The disparate rate of decay with studies of adults placed on antiretroviral drugs suggests that antigen specific T cell responses are driven by the natural rate of decay of the T cell sub-populations themselves.

Indexed as

exposed seronegativeHIV-1neonatesT cellsvertically exposed

Identifiers

PMID22566883
PMCPMC3341962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.